• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度年轻2型糖尿病成年人危险因素及共病的真实世界证据:一项真实青年(糖尿病)研究

REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study.

作者信息

Saboo Banshi, Agarwal Sanjay, Gupta Sunil, Makkar Brij, Panneerselvam A, Sahoo Abhay Kumar, Ramchandani G D, Das Sambit, Erande Suhas, Kadam Yogesh, Abhyankar Mahesh V, Revankar Santosh

机构信息

Department of Diabetology, Diabetes Care and Hormone Clinic, Ambawadi, Ahmedabad, Gujarat, India.

Department of Internal Medicine, Dr. Sanjay Agarwal's Aegle Clinic, City, Pune, Maharashtra, India.

出版信息

J Family Med Prim Care. 2021 Sep;10(9):3444-3452. doi: 10.4103/jfmpc.jfmpc_2010_20. Epub 2021 Sep 30.

DOI:10.4103/jfmpc.jfmpc_2010_20
PMID:34760771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8565132/
Abstract

OBJECTIVE

To assess the clinical characteristics, risk factors, and comorbidities associated with type 2 diabetes mellitus (T2DM) in young adult patients.

METHODS

This is a retrospective, multicentric real-world study that included young adults (18-45 years) with T2DM. Primary information including demographics, medical and family history, biochemical measures (pre-and post-prandial blood glucose levels, glycosylated hemoglobin [HbA1c] and blood pressure, and lipid parameters) smoking and drinking habits were collected retrospectively from the medical records of the respective hospitals/clinics. Data were analyzed using descriptive and appropriate comparative statistics.

RESULTS

A total of 22,921 patients from 623 sites were included. The median age was 37.0 years and the majority were men (61.6%). The proportion of patients from the age group >35-≤45 years was 62.7%. Among all patients, 46.9% had only T2DM; however, 53.1% of patients had T2DM with other comorbidities (T2DM with hypertension, dyslipidemia, and both). The majority of patients had elevated body mass index (BMI) (overweight, 46.6%; and obese, 22.9%). Family history of T2DM (68.1%) was most common in overall population. Sedentary lifestyle (63.1%), alcohol consumption (38.9%), and regular smoking (23.1%) were the most common associations in patients with T2DM with dyslipidemia and hypertension. Uncontrolled HbA1c level (≥7%) were observed in 79.2% of patients. The level of HbA1c was significantly increased with the duration of T2DM and sedentary lifestyle ( < 0.001).

CONCLUSION

Higher BMI, family history of T2DM, sedentary lifestyle, alcohol consumption, and smoking were the most common risk facors, while hypertension and dyslipidemia were the most prevalent comorbidities associated with T2DM in young Indian adults.

摘要

目的

评估年轻成年2型糖尿病(T2DM)患者的临床特征、危险因素及合并症。

方法

这是一项回顾性、多中心的真实世界研究,纳入了18至45岁的T2DM年轻成年人。从各医院/诊所的病历中回顾性收集包括人口统计学、病史和家族史、生化指标(餐前和餐后血糖水平、糖化血红蛋白[HbA1c]、血压和血脂参数)、吸烟和饮酒习惯等主要信息。使用描述性和适当的比较统计方法进行数据分析。

结果

共纳入来自623个研究点的22921例患者。中位年龄为37.0岁,大多数为男性(61.6%)。年龄在>35至≤45岁组的患者比例为62.7%。在所有患者中,46.9%仅患有T2DM;然而,53.1%的患者患有T2DM合并其他合并症(T2DM合并高血压、血脂异常或两者皆有)。大多数患者体重指数(BMI)升高(超重,46.6%;肥胖,22.9%)。T2DM家族史(68.1%)在总体人群中最为常见。久坐不动的生活方式(63.1%)、饮酒(38.9%)和经常吸烟(23.1%)是T2DM合并血脂异常和高血压患者中最常见的关联因素。79.2%的患者糖化血红蛋白(HbA1c)水平未得到控制(≥7%)。HbA1c水平随T2DM病程和久坐不动的生活方式显著升高(<0.001)。

结论

较高的BMI、T2DM家族史、久坐不动的生活方式、饮酒和吸烟是最常见的危险因素,而高血压和血脂异常是印度年轻成年人中与T2DM相关的最常见合并症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/80d9d34af86e/JFMPC-10-3444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/58f2bc34fea3/JFMPC-10-3444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/0e92f32150b5/JFMPC-10-3444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/80d9d34af86e/JFMPC-10-3444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/58f2bc34fea3/JFMPC-10-3444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/0e92f32150b5/JFMPC-10-3444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ac0/8565132/80d9d34af86e/JFMPC-10-3444-g003.jpg

相似文献

1
REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study.印度年轻2型糖尿病成年人危险因素及共病的真实世界证据:一项真实青年(糖尿病)研究
J Family Med Prim Care. 2021 Sep;10(9):3444-3452. doi: 10.4103/jfmpc.jfmpc_2010_20. Epub 2021 Sep 30.
2
Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study.印度年轻高血压患者的风险因素和合并症:REAL YOUNG(高血压)研究
Integr Blood Press Control. 2021 Feb 26;14:31-41. doi: 10.2147/IBPC.S272548. eCollection 2021.
3
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study.印度血脂异常的年轻住院/门诊患者的危险因素、合并症及致动脉粥样硬化性血脂异常:REAL YOUNG(血脂异常)研究
J Family Med Prim Care. 2020 Aug 25;9(8):4156-4164. doi: 10.4103/jfmpc.jfmpc_546_20. eCollection 2020 Aug.
4
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57).日本2型糖尿病中胰高血糖素样肽-1受体激动剂的使用情况:一项回顾性数据库分析(JDDM 57)
Diabetes Ther. 2021 Jan;12(1):345-361. doi: 10.1007/s13300-020-00977-w. Epub 2020 Dec 9.
5
Clinical and Demographic Characteristics of Patients with Coexistent Hypertension, Type 2 Diabetes Mellitus, and Dyslipidemia: A Retrospective Study from India.高血压、2型糖尿病和血脂异常并存患者的临床和人口统计学特征:一项来自印度的回顾性研究。
Drugs Real World Outcomes. 2024 Mar;11(1):167-176. doi: 10.1007/s40801-023-00400-3. Epub 2023 Dec 1.
6
Vitamin D and Elevated Serum Uric Acid as Novel Predictors and Prognostic Markers for Type 2 Diabetes Mellitus.维生素D与血清尿酸升高作为2型糖尿病的新型预测指标和预后标志物
J Pharm Bioallied Sci. 2019 Apr-Jun;11(2):127-132. doi: 10.4103/jpbs.JPBS_240_18.
7
Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes Management.关于格列美脲、二甲双胍和伏格列波糖固定剂量复方制剂在2型糖尿病管理中使用模式的多中心回顾性观察研究
Cureus. 2024 Jan 10;16(1):e52064. doi: 10.7759/cureus.52064. eCollection 2024 Jan.
8
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
9
Cigarette Smoking Is Negatively Associated with the Prevalence of Type 2 Diabetes in Middle-Aged Men with Normal Weight but Positively Associated with Stroke in Men.吸烟与体重正常的中年男性 2 型糖尿病患病率呈负相关,但与男性中风呈正相关。
J Diabetes Res. 2019 Sep 11;2019:1853018. doi: 10.1155/2019/1853018. eCollection 2019.
10
Real-World Clinical Experience on the Usage of High-Dose Metformin (1500-2500 mg/day) in Type 2 Diabetes Management.高剂量二甲双胍(1500 - 2500毫克/天)用于2型糖尿病管理的真实世界临床经验
Clin Med Insights Endocrinol Diabetes. 2021 Jul 13;14:11795514211030513. doi: 10.1177/11795514211030513. eCollection 2021.

引用本文的文献

1
Baseline clinical and biochemical profiles of type 2 diabetes patients enrolled in a lifestyle management program in India, a cross-sectional study.印度一项生活方式管理项目中2型糖尿病患者的基线临床和生化特征,一项横断面研究。
Sci Rep. 2025 Mar 25;15(1):10275. doi: 10.1038/s41598-025-94694-8.

本文引用的文献

1
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
2
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
3
Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
印度 2 型糖尿病患者血糖控制的真实世界证据:TIGHT 研究。
BMJ Open Diabetes Res Care. 2019 Jul 14;7(1):e000654. doi: 10.1136/bmjdrc-2019-000654. eCollection 2019.
4
Heterogeneity in the aetiology of diabetes mellitus in young adults: A prospective study from north India.青年人群中糖尿病病因的异质性:来自印度北部的一项前瞻性研究。
Indian J Med Res. 2019 Apr;149(4):479-488. doi: 10.4103/ijmr.IJMR_1004_17.
5
The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990-2016.糖尿病负担日益加重,印度各邦情况不一:1990-2016 年全球疾病负担研究。
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362. doi: 10.1016/S2214-109X(18)30387-5. Epub 2018 Sep 12.
6
Association between insulin resistance and the development of cardiovascular disease.胰岛素抵抗与心血管疾病的发展之间的关系。
Cardiovasc Diabetol. 2018 Aug 31;17(1):122. doi: 10.1186/s12933-018-0762-4.
7
Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses.2 型糖尿病的危险因素:荟萃分析的暴露范围伞式综述。
PLoS One. 2018 Mar 20;13(3):e0194127. doi: 10.1371/journal.pone.0194127. eCollection 2018.
8
Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.印度 15 个邦的糖尿病和糖尿病前期患病率:ICMR-INDIAB 基于人群的横断面研究结果。
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. doi: 10.1016/S2213-8587(17)30174-2. Epub 2017 Jun 7.
9
Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India.糖尿病与高血压合并症的患病率及决定因素:来自印度非传染性疾病风险因素STEPS调查的证据
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S459-S465. doi: 10.1016/j.dsx.2017.03.036. Epub 2017 Mar 31.
10
Prevalence of risk factors for non-communicable diseases in rural & urban Tamil Nadu.泰米尔纳德邦农村和城市地区非传染性疾病风险因素的患病率。
Indian J Med Res. 2016 Sep;144(3):460-471. doi: 10.4103/0971-5916.198668.